Skip to main content

Poster Hall

Real-world outcomes in patients with RA remaining on first-line TNFi

Sponsored by AbbVie Medical Affairs + Health Impact

Time to first musculoskeletal response of an IL-23i in PsA

Sponsored by AbbVie Medical Affairs + Health Impact

Long-term maintenance of response of an IL-23i in PsA

Sponsored by AbbVie Medical Affairs + Health Impact
 

More Virtual Posters

Abbvie Zoster Virtual Poster

Sponsored by AbbVie Medical Affairs

Zoster vaccine immunogenicity with JAKi treatment

AbbVie Poster (Sept 2024)

Sponsored by AbbVie Medical Affairs

Safety of a JAKi Across 15,000 Patient-Years of Data

×